^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Tolsura (SUBA-itraconazole)

    i
    Other names: SUBA-Cap
    Associations

    News

    Trials
    Company:
    Inhibitor Therap, Mayne Pharma
    Drug class:
    Hedgehog cell-signalling pathway inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    HITMAN: Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer (clinicaltrials.gov)
    P1/2, N=12, Completed, St Vincent's Hospital, Sydney | Active, not recruiting --> Completed | Trial completion date: Jul 2024 --> Oct 2023 | Trial primary completion date: Mar 2023 --> Aug 2023
    Trial completion • Trial completion date • Trial primary completion date
    |
    hydroxychloroquine • Tolsura (SUBA-itraconazole)
    over4years
    Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) (clinicaltrials.gov)
    P2b, N=38, Completed, HedgePath Pharmaceuticals, Inc. | Active, not recruiting --> Completed
    Clinical • Trial completion
    |
    GLI1 (GLI Family Zinc Finger 1)
    |
    GLI1 expression
    |
    Tolsura (SUBA-itraconazole)